BCK Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AACR
BCK Partners's JNJ Position: Q2 2026 in Review
BCK Partners reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, selling an estimated $16.3K and leaving 2,737 shares worth $695K. The position accounts for 0.34% of the portfolio, ranked #13.
BCK Partners first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. The position peaked at $715K in Q1 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- BCK Partners held 2,737 shares of Johnson & Johnson worth $695K as of Q2 2026.
- BCK Partners sold 70 Johnson & Johnson shares in Q2 2026, an estimated $16.3K.
- Johnson & Johnson made up 0.34% of BCK Partners's portfolio in Q2 2026, its #13 holding.
- BCK Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
- BCK Partners's Johnson & Johnson position peaked at $715K in Q1 2022.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on BCK Partners's 13F filing for Q2 2026, filed 20 Jul 2026.